ACB is a horrible company and one of my least favorite in the pot sector. That being said, technically it's looking healthier after testing and holding the $6.70 range a number of times and re-capturing the short-term MA (8EMA). Keep an eye on this for a break of the short-term trendline.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.